Prevalence and duration of symptoms among moderate and severe COVID-19 patients 12 months after discharge

Detalles Bibliográficos
Autores principales: Tortajada, C., Navarro, A., Andreu-Ballester, J. C., Mayor, A., Añón, S., Flores, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
CE-Research Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754532/
https://www.ncbi.nlm.nih.gov/pubmed/35023003
http://dx.doi.org/10.1007/s11739-021-02895-6
_version_ 1784632290505129984
author Tortajada, C.
Navarro, A.
Andreu-Ballester, J. C.
Mayor, A.
Añón, S.
Flores, J.
author_facet Tortajada, C.
Navarro, A.
Andreu-Ballester, J. C.
Mayor, A.
Añón, S.
Flores, J.
author_sort Tortajada, C.
collection PubMed
description
format Online
Article
Text
id pubmed-8754532
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-87545322022-01-13 Prevalence and duration of symptoms among moderate and severe COVID-19 patients 12 months after discharge Tortajada, C. Navarro, A. Andreu-Ballester, J. C. Mayor, A. Añón, S. Flores, J. Intern Emerg Med CE-Research Letter to the Editor Springer International Publishing 2022-01-13 2022 /pmc/articles/PMC8754532/ /pubmed/35023003 http://dx.doi.org/10.1007/s11739-021-02895-6 Text en © Società Italiana di Medicina Interna (SIMI) 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle CE-Research Letter to the Editor
Tortajada, C.
Navarro, A.
Andreu-Ballester, J. C.
Mayor, A.
Añón, S.
Flores, J.
Prevalence and duration of symptoms among moderate and severe COVID-19 patients 12 months after discharge
title Prevalence and duration of symptoms among moderate and severe COVID-19 patients 12 months after discharge
title_full Prevalence and duration of symptoms among moderate and severe COVID-19 patients 12 months after discharge
title_fullStr Prevalence and duration of symptoms among moderate and severe COVID-19 patients 12 months after discharge
title_full_unstemmed Prevalence and duration of symptoms among moderate and severe COVID-19 patients 12 months after discharge
title_short Prevalence and duration of symptoms among moderate and severe COVID-19 patients 12 months after discharge
title_sort prevalence and duration of symptoms among moderate and severe covid-19 patients 12 months after discharge
topic CE-Research Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754532/
https://www.ncbi.nlm.nih.gov/pubmed/35023003
http://dx.doi.org/10.1007/s11739-021-02895-6
work_keys_str_mv AT tortajadac prevalenceanddurationofsymptomsamongmoderateandseverecovid19patients12monthsafterdischarge
AT navarroa prevalenceanddurationofsymptomsamongmoderateandseverecovid19patients12monthsafterdischarge
AT andreuballesterjc prevalenceanddurationofsymptomsamongmoderateandseverecovid19patients12monthsafterdischarge
AT mayora prevalenceanddurationofsymptomsamongmoderateandseverecovid19patients12monthsafterdischarge
AT anons prevalenceanddurationofsymptomsamongmoderateandseverecovid19patients12monthsafterdischarge
AT floresj prevalenceanddurationofsymptomsamongmoderateandseverecovid19patients12monthsafterdischarge

Ejemplares similares